Insider · CIK 0001750079

Parker Albert P

Reports to the SEC for 2 companies · ALAMEDA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001750079

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-10-10	Zynerba Pharmaceuticals, Inc.U Disposition from Tender	Chief Legal Officer	UDisposition from Tender	−33.7K sh	—	—	193,333
2023-10-10	Zynerba Pharmaceuticals, Inc.A Award	Chief Legal Officer	AAward	+85K sh	—	—	278,333
2023-10-10	Zynerba Pharmaceuticals, Inc.U Disposition from Tender	Chief Legal Officer	UDisposition from Tender	−278K sh	—	—	0
2023-10-10	Zynerba Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−200K sh	—	—	0
2023-02-15	Zynerba Pharmaceuticals, Inc.S Sale	Chief Legal Officer	SSale	−3,173 sh	$0.54	−$1,719.131	227,018
2023-02-08	Zynerba Pharmaceuticals, Inc.F Tax Payment	Chief Legal Officer	FTax Payment	−5,463 sh	$0.60	−$3,258.68	230,191
2023-02-07	Zynerba Pharmaceuticals, Inc.A Award	Chief Legal Officer	AAward	+18.9K sh	—	—	235,654
2023-02-01	Zynerba Pharmaceuticals, Inc.F Tax Payment	Chief Legal Officer	FTax Payment	−5,841 sh	$0.60	−$3,476.563	216,790
2023-01-31	Zynerba Pharmaceuticals, Inc.A Award	Chief Legal Officer	AAward	+17.6K sh	—	—	222,631
2023-01-24	Zynerba Pharmaceuticals, Inc.A Award	Chief Legal Officer	AAward	+170K sh	—	—	205,000
2022-02-14	Zynerba Pharmaceuticals, Inc.A Award	Chief Legal Officer	AAward	+35K sh	—	—	35,000
2022-02-14	Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+200K sh	—	—	200,000
2020-12-11	IMDXInsight Molecular Diagnostics Inc.A Award	COO	AAward	+5,586 sh	—	—	10,586
2020-08-03	IMDXInsight Molecular Diagnostics Inc.P Purchase	COO	PPurchase	+5,000 sh	$1.33	+$6,648	5,000
2020-02-10	IMDXInsight Molecular Diagnostics Inc. · Option to purchase common stockA Award	COO	AAward	+204K sh	—	—	204,000
2019-03-14	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockA Award	COO	AAward	+200K sh	—	—	200,000

Recent filings

Accepted (ET)
Oct 114
Parker Albert P0001140361-23-047729
SEC(opens sec.gov)
Feb 174
Parker Albert P0001062993-23-004049
SEC(opens sec.gov)
Feb 94
Parker Albert P0000899243-23-004441
SEC(opens sec.gov)
Feb 24
Parker Albert P0000899243-23-003730
SEC(opens sec.gov)
Jan 254
Parker Albert P0001062993-23-001388
SEC(opens sec.gov)
Feb 154
Parker Albert P0001062993-22-004450
SEC(opens sec.gov)
Dec 154
Parker Albert P0001493152-20-023590
SEC(opens sec.gov)
Aug 54
Parker Albert P0001493152-20-014772
SEC(opens sec.gov)
Feb 124
Parker Albert P0001493152-20-002154
SEC(opens sec.gov)
Mar 184
Parker Albert P0001209191-19-020133
SEC(opens sec.gov)

Companies

Address

C/O ONCOCYTE CORPORATION 1010 ATLANTIC AVENUE, SUITE 102

ALAMEDA, CA, 94501